Clinical application of a systems model of apoptosis execution for the prediction of colorectal cancer therapy responses and personalisation of therapy
View abstract on PubMed
Summary
This summary is machine-generated.Systems biology accurately predicts colorectal cancer patient response to chemotherapy, outperforming traditional methods. This approach also identifies personalized treatments by analyzing cancer cell apoptosis susceptibility.
Area Of Science
- Oncology
- Systems Biology
- Molecular Biology
Background
- Accurate prognosis and personalized treatment are crucial for colorectal cancer management.
- Identifying tools to predict patient response to chemotherapy and targeted therapies is essential.
Purpose Of The Study
- To evaluate a systems biology strategy for predicting colorectal cancer patient response to 5-fluorouracil chemotherapy.
- To identify alternative targeted treatments by analyzing cancer cell apoptosis susceptibility.
Main Methods
- Quantified five apoptosis-regulating proteins in tumor and normal colonic tissue.
- Employed systems simulations of apoptosis signaling to predict apoptosis execution.
- Assessed novel apoptosis-inducing therapeutics efficacy in apoptosis-incompetent tumors.
Main Results
- Apoptosis susceptibility in colorectal tumors decreases with advancing disease stage.
- Systems-level analysis predicted patient outcomes with 85% accuracy for 5-fluorouracil chemotherapy.
- Significantly outperformed traditional statistical approaches in outcome prediction.
- Revealed marked inter-individual differences in response to novel therapeutics.
Conclusions
- This study provides the first proof-of-concept for systems biology in predicting patient outcomes.
- Demonstrates significant clinical potential for systems biology in personalized cancer treatment paradigms.